Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barrow

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Biochemical and Biophysical Research Communications|July 2, 2026
A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cellsAlexander J Sedgwick, James Roest, Geoff Zhang, et al.
The Prostate|September 11, 2001
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathwaysH E Jones, D Barrow, C M Dutkowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotypeXiaobin Tang, Linjie Tian, Gloria Esteso, et al.
Molecular and Cellular Endocrinology|February 13, 2001
Non-steroidal and steroidal sulfamates: new drugs for cancer therapyA Purohit, L W Woo, D Barrow, et al.
Physical Review Letters|October 4, 2014
Limits on a gravitational field dependence of the proton-electron mass ratio from H2 in white dwarf starsJ Bagdonaite, E J Salumbides, S P Preval, et al.
Endocrine-Related Cancer|August 23, 2005
Development of strategies for the use of anti-growth factor treatmentsH E Jones, J M W Gee, K M Taylor, et al.
The Journal of Biological Chemistry|December 23, 1999
The human and mouse GATA-6 genes utilize two promoters and two initiation codonsA Brewer, C Gove, A Davies, et al.
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancerR I Nicholson, I R Hutcheson, S E Hiscox, et al.
The Australian Journal of Experimental Biology and Medical Science|April 1, 1981
Uridine and inosine: pressor nucleosides from man, rat and dogG J Macdonald, E Burcher, W K Fisher, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|June 11, 1997
New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145H E Jones, C M Dutkowski, D Barrow, et al.
Biochemical and Biophysical Research Communications|July 2, 2026
A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cellsAlexander J Sedgwick, James Roest, Geoff Zhang, et al.
The Prostate|September 11, 2001
Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathwaysH E Jones, D Barrow, C M Dutkowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotypeXiaobin Tang, Linjie Tian, Gloria Esteso, et al.
Molecular and Cellular Endocrinology|February 13, 2001
Non-steroidal and steroidal sulfamates: new drugs for cancer therapyA Purohit, L W Woo, D Barrow, et al.
Physical Review Letters|October 4, 2014
Limits on a gravitational field dependence of the proton-electron mass ratio from H2 in white dwarf starsJ Bagdonaite, E J Salumbides, S P Preval, et al.
Endocrine-Related Cancer|August 23, 2005
Development of strategies for the use of anti-growth factor treatmentsH E Jones, J M W Gee, K M Taylor, et al.
The Journal of Biological Chemistry|December 23, 1999
The human and mouse GATA-6 genes utilize two promoters and two initiation codonsA Brewer, C Gove, A Davies, et al.
Endocrine-Related Cancer|August 23, 2005
Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancerR I Nicholson, I R Hutcheson, S E Hiscox, et al.
The Australian Journal of Experimental Biology and Medical Science|April 1, 1981
Uridine and inosine: pressor nucleosides from man, rat and dogG J Macdonald, E Burcher, W K Fisher, et al.
Pageof 12